Arvind Remedies Limited Company Profile
|
|
Arvind Remedies (ARVREMED), is engaged in the manufacture, marketing and export of allopathic and ayurvedic pharmaceutical products. Established in 1988 as a private limited company, the company went pubic in April 1996. It is promoted by Arvind Shah, the managing director and chief executive officer.
The company has made significant contribution in cardiology, dermatology, nephrology and diabetes. It manufactures allopathic ethical products like Nimser (anti-inflammatory), Carolox (anti infectives), Vitoxid AO (antioxidant), Artin 250 (anti rheumatic), Dispas DT (anti spasmodic),..etc; branded generic drugs like Alben 400 (anthelmintic), Amoxycillin DT (semi-synthetic), Erythromycin (antibiotic), Racy 500 (antibiotic), ..etc; generic products like trypsin chymotrypsin (acute inflammatory oedema), verapamil (anti hypertensive), ..etc. It also produces ayurvedic products like artin oil, Hygenex, Pankare, Pankare (tablet), Solufat, Sorexil, Stresof, and Utritone.
The company`s state-of-the-art manufacturing facility and research and development lab is located in Kakkalur, Chennai and has been certified with GMP under WHO norms. All products are ISO 9002 certified. The annual capacity of the company is 1.47 million tablets, 421,000 capsules, 2140 Kg ointments and 2,004 liters of liquids.
The company`s Indian client portfolio includes prestigious defence establishments, ESI, CGHS, central and state government institutions, public sector companies, P&T, railways and world bank projects. It exports to Africa, Commonwealth of Independent States and Asian countries. It has commenced registration of products in several countries including Malaysia, Tanzania, Sri Lanka, Ukraine, Nigeria and Nepal.
The registered office is at 190, Poonamallee High Road, Chennai-600084, Tamil Nadu.
Financials
The company disclosed rise of 149.05% in standalone net profit on y-o-y basis to Rs 55.35 million, while total income rose 14.77% y-o-y basis to Rs 1.01 billion for the quarter ended March 2011.
|
|
ARL Intraday Realtime Chart
|
|
